SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Chugai Pharmaceutical Co., Ltd. (4519.T) News

Track canonical SquawkNews coverage tagged to 4519.T, Chugai Pharmaceutical Co., Ltd.. This hub brings together deduplicated headlines about tokyo, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 4519.T Asset equity Sector Markets 90 days 1 Last 6,362 Updated Sep 28, 2026, 07:06 AM UTC Open live news feed
L Chugai stops Gym329 obesity development, returns license and resumes SMA work Reuters says Chugai Pharmaceutical Co Ltd is discontinuing development of Gym329 (Emugrobart) for obesity, returning the license and resuming development for SMA. EQUITY | Sep 28, 2026, 07:06 AM UTC